Accuray (ARAY) vs Pulsenmore (PLSM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Pulsenmore is the larger company by market cap ($8.4 million vs $6.2 million), about 1.3 times the size. Accuray converts more of its revenue into profit, with a net margin of -12.2% versus -39.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ARAY | PLSM |
|---|---|---|
| Share price | $2.08 | $1.29 |
| Market cap | $6.22M | $8.39M |
| 1-day change | -2.12% | -4.44% |
| YTD return | +153.05% | — |
| 1-year return | +97.62% | — |
| 5-year return | -59.47% | — |
| EPS (TTM) | $-5.60 | $-1.33 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $401.95M | $12.55M |
| Revenue growth (YoY) | -12.34% | — |
| Net income (latest FY) | $-49.19M | $-4.97M |
| Gross margin | 27.73% | 84.16% |
| Operating margin | -6.58% | — |
| Net margin | -12.24% | -39.61% |
| 52-week high | $45.20 | $12.97 |
| 52-week low | $2.05 | $1.27 |
| Distance from 52-week high | -95.41% | -90.05% |
| Analyst consensus | none | — |
| Average volume | 201.35K | 49.70K |
| Shares outstanding | 3.00M | 6.50M |
| Employees | 809 | 71 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Accuray is more profitable, keeping -12.2 cents of every revenue dollar as net income versus -39.6 cents for Pulsenmore.
About Accuray
ARAY stock →Accuray Incorporated engages in the design, development, and sale of radiosurgery and radiation therapy systems for the treatment of tumors throughout the body in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate.
Health Care · Medical/Dental Instruments · 809 employees
About Pulsenmore
PLSM stock →Pulsenmore Ltd., a medical device company, engages in the research, development, manufacture, marketing, and sale of portable ultrasound solutions. The company provides Pulsenmore ES and Pulsenmore FC products in the United States, the United Kingdom, Northern Ireland, and Europe.
Health Care · Medical/Dental Instruments · 71 employees
ARAY vs PLSM FAQ
Which is bigger, Accuray or Pulsenmore?
Pulsenmore (PLSM) is larger, with a market capitalization of $8.39M compared with $6.22M for Accuray (ARAY).
Are Accuray and Pulsenmore in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.